MELK and breast cancer: Kaplan–Meier survival analyses were conducted on data from the Kaplan–Meier Plotter database for breast cancer stratified by median MELK expression to evaluate the impact of MELK expression on clinical outcomes, including overall survival (OS), recurrence-free survival (RFS), and distant metastasis-free survival (DMFS), in breast cancer patients [18].